Citigroup
TSRX

Citigroup’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Citigroup’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-27,414
Closed -$223K – 5507
2013
Q2 		$223K Buy
+27,414
New +$223K ﹤0.01% 2655